Regional Workshop for Conversion of Emergency Use Authorization (EUA) to Full Marketing Authorization (MA) for Pandemic Vaccines held

21-23 November | Kathmandu, Bagmati Province - To integrate pandemic vaccines into the national immunization programmes in countries of the WHO South-East Asia Region, vaccine regulators, and officials from WHO, deliberated strategies to enable Member countries to transition from the use of COVID-19 vaccines under Emergency Use Authorization to regular marketing authorization. During the 3-day workshop, members of the National Regulatory Authorities and National Control Laboratories of WHO SEARO Member States, experts from WHO, and the Therapeutic Goods Administration Australia deliberated on several issues and examined key considerations to meet regulatory requirements and licensing regulations for pandemic vaccines.